ZYBERNO
Stock Report
Updated Aug 27, 2026

NEWGENIVF GROUP LIMITED (NIVFW)

Healthcare • NASDAQ

$0.02

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
21.0/100
POOR BUSINESS
NEWGENIVF GROUP LIMITED (NIVFW) scores 21/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (0.0%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.04x)
Operating Margin (Operational Efficiency):CRITICAL (0.0%)
Return on Capital (Capital Efficiency):CRITICAL (-31.3%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

NEWGENIVF GROUP LIMITED (NIVFW) stock report — Zyberno Score 21/100 (POOR BUSINESS). Full financial analysis on Zyberno.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:0.02
Market Cap:$851.17

Valuation Multiples (2)

P/B Ratio:0.00x
Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:-$247.31K

Price Action & Momentum (1)

% of 52-Week High:20.6%
B. Profitability Assessment

Return Metrics (3)

Reinvestment Rate:-12.4%
Fundamental Growth Rate (g):3.9%

Margin Analysis (1)

Ebitda Margin:-44.4%

Yield Metrics (2)

Earnings Yield:-$999.00
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:3.12x
Quick Ratio:2.98x
Cash Ratio:0.32x

Leverage Analysis (3)

Debt To Equity Ttm:0.04x
Debt-to-Equity Ratio:0.04x
Debt To Ebitda:-999.00x

Coverage Ratios (2)

Interest Coverage Ratio:-17.40x
Times Interest Earned:-17.40

Capital Structure (4)

Working Capital:5,017,220.00
Cash And Cash Equivalents:758,621.00
Long Term Debt:$272.36K
Net Debt:-$248.16K
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

$23.71M
Cost Of Revenue Ttm:$3.77M

Profitability Breakdown (2)

$19.94M-$10.73M

Bottom Line Performance (3)

$9.88M
Income Before Tax:$9.73M
Ebitda Ttm:-10,538,352.00

Operating Expenses (5)

Operating Expenses:11,682,307.00
R And D Expense:0.00
Sga Expense:10,493,596.00
Income Tax Expense:-$486.71K
Interest Expense:616,423.00

Expense Ratios (3)

R And D To Revenue Percentage:0.0%
Sga To Revenue Percentage:44.3%
Ebitda Margin:-44.4%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$32.72M
Current Assets:$7.38M
Ppe Net:1,789,110.00
Goodwill:0.00
Intangible Assets:$21.42M

Liability Structure (4)

Total Liabilities:6,736,076.00
Current Liabilities:2,366,351.00
Long Term Debt:$272.36K
Short Term Debt:$238.11K

Equity & Capital (3)

Equity:$25.99M
Retained Earnings:$8.89M
Common Stock:10,000,000.00

Working Capital Items (3)

Accounts Receivable:166,531.00
Inventory:335,360.00
Accounts Payable:779,280.00

Special Items (2)

Contract Liabilities:111,981.00
Stock Based Compensation:0.00
C. Cash Flow Analysis

Operating Activities (2)

-$10.93M-$11.06M

Investment Activities (1)

Investing Cash Flow:-$7.56M

Financing Activities (3)

Financing Cash Flow:$18.99M
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:12,620,496.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:188,109.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (1)

Earnings Per Share Ttm:$214.73

Revenue & Cash Per Share (2)

Sales Per Share Ttm:515.30
Operating Cash Flow Per Share:-$237.48

Book Value & Capital (2)

Book Value Per Share:$564.82
Cash Per Share:16.49

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.72x
Working Capital Turnover Ttm:4.73x

Receivables Management (2)

Receivables Turnover Ttm:142.37x
Days Sales Outstanding Ttm:2.56

Inventory Management (2)

Inventory Turnover Ttm:11.24x
Days Inventory Outstanding Ttm:32.46

Payables & Cash Cycle (2)

Days Payable Outstanding:75.44
Cash Conversion Cycle:-40.41
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:100.00
Quality Score:70.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Damodaran Growth Analysis (2)

Reinvestment Rate:-12.4%
Fundamental Growth Rate (g):3.9%
B. Log-Linear Regression Growth Analysis
C. Company Profile & Context

Corporate Information (6)

Symbol:NIVFW
Company Name:NEWGENIVF GROUP LIMITED
Sector:Healthcare
Industry:Services-Misc Health & Allied Services, NEC
Exchange:NASDAQ
Country:Thailand

Market Classification (3)

Market Cap Category:N/A
Price Category:penny
Volume Category:N/A

Share Structure (3)

Shares Outstanding:46.01K
Shares Outstanding Basic:46.01K
Shares Outstanding Diluted:3.25M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-08-27 00:28:36 UTC
Data Timestamp:2026-08-27T00:28:36.340462
Scroll to Top